DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of beta-amyloid (Abeta).DSS30 can be used for the prevention and treatment of neurodegenerative diseases such as Alzheimers disease.
Molecular Weight:
367.87
Purity:
>99.99%
CAS Number:
[883027-32-5]
Formula:
C16H14ClNO3S2
Target:
Beta Amyloid|||BACE|||CDK
T61439
* VAT and and shipping costs not included. Errors and price changes excepted